ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 153 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $4,122,000 | +251.4% | 77,106 | +218.6% | 0.33% | +178.3% |
| Q2 2020 | $1,173,000 | -86.7% | 24,201 | -90.1% | 0.12% | -74.6% |
| Q3 2019 | $8,825,000 | +771.2% | 245,234 | +546.8% | 0.47% | +1110.3% |
| Q2 2019 | $1,013,000 | +46.8% | 37,915 | +47.5% | 0.04% | -2.5% |
| Q1 2019 | $690,000 | -65.9% | 25,700 | -73.6% | 0.04% | -43.7% |
| Q3 2018 | $2,024,000 | +41.9% | 97,500 | +134.9% | 0.07% | +222.7% |
| Q1 2017 | $1,426,000 | -51.8% | 41,500 | -54.5% | 0.02% | -84.1% |
| Q2 2016 | $2,960,000 | +1025.5% | 91,200 | +1347.6% | 0.14% | +245.0% |
| Q2 2015 | $263,000 | -8.7% | 6,300 | -30.8% | 0.04% | -9.1% |
| Q4 2014 | $288,000 | -24.4% | 9,100 | -40.9% | 0.04% | -39.7% |
| Q3 2014 | $381,000 | -35.1% | 15,400 | -34.5% | 0.07% | +28.1% |
| Q4 2013 | $587,000 | – | 23,500 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 25,819,768 | $887,684,000 | 7.26% |
| Avoro Capital Advisors LLC | 1,630,000 | $56,039,000 | 7.16% |
| ACUTA CAPITAL PARTNERS, LLC | 572,756 | $19,691,000 | 4.67% |
| HWG Holdings LP | 100,994 | $3,472,000 | 4.38% |
| HARVEY CAPITAL MANAGEMENT INC | 230,350 | $7,919,000 | 3.56% |
| SECTORAL ASSET MANAGEMENT INC | 671,113 | $23,073,000 | 2.70% |
| Palo Alto Investors LP | 1,590,430 | $54,679,000 | 2.58% |
| Ghost Tree Capital, LLC | 350,000 | $12,033,000 | 2.24% |
| GARRISON BRADFORD & ASSOCIATES INC | 72,550 | $2,494,000 | 2.20% |
| EMORY UNIVERSITY | 56,135 | $1,930,000 | 1.82% |